Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids

Gene Therapy

Volumn 11, Issue 10, 2004, Pages 829-837

  Booth, M J ^a   Mistry, A ^b   Li, X ^c   Thrasher, A ^b   Coffin, R S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Biovex Ltd   (United Kingdom)

Author keywords

Adeno associated virus; Herpes simplex virus; Viral vector

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC CODE; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROVIRUS; RAT; SCALE UP; SOUTHERN BLOTTING; TRANSGENE; VIRUS CAPSID; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS TITRATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; RECOMBINATION, GENETIC; SIMPLEXVIRUS; TRANSFECTION; TRANSGENES; VIRAL PROTEINS; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; SIMPLEXVIRUS;

EID: 2642537075     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302226     Document Type: Article

References (31)

1. Bainbridge JW et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Therapy 2002; 9: 320-326.
2. Melo LG et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002; 105: 602-607.
3. Davidson BL et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci 2000; 97: 3428-3432.
4. Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
5. Flotte TR. Recombinant adeno-associated virus gene therapy for cystic fibrosis and alpha(1)-antitrypsin deficiency. Chest 2002; 121 (3 Suppl): 98S-102S.
6. Herzog RW, High KA. Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy. Thromb Haemost 1999; 82: 540-546.
7. Kay MA et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-261.
8. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745-2760.
9. Matsushita T et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Therapy 1998; 5: 938-945.
10. Anderson R et al. A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction. J Virol Methods 2000; 85: 23-34.
11. Zhong L, Hayward GS. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays. J Virol 1997; 71: 3146-3160.
12. Brument N et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol Ther 2002; 6: 678-686.
13. Mistry AR et al. High-titer stocks of adeno-associated virus from replicating amplicons and herpes vectors. Methods Mol Med 2002; 69: 445-460.
14. Conway JE et al. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Therapy 1999; 6: 986-993.
15. Howard MK et al. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34. Gene Therapy 1998; 5: 1137-1147.
16. Grimm D et al. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Therapy 1999; 6: 1322-1330.
17. Weitzman MD, Fisher KJ, Wilson JM. Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J Virol 1996; 70: 1845-1854.
18. Jing XJ et al. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus. Virology 2001; 291: 140-151.
19. Lilley CE et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J Virol 2001; 75: 4343-4356.
20. Skorupa AF et al. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999; 160: 17-27.
21. Ma HI et al. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Therapy 2002; 9: 2-11.
22. Hudde T et al. Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium. Cornea 2000; 19: 369-373.
23. Grimm D, Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther 1999; 10: 2445-2450.
24. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 2000; 6: 433-440.
25. Weindler FW, Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J Virol 1991; 65: 2476-2483.
26. Ward P et al. Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. J Virol 2001; 75: 10250-10258.
27. Nada S, Trempe JP. Characterization of adeno-associated virus rep protein inhibition of adenovirus E2a gene expression. Virology 2002; 293: 345-355.
28. Soliman TM, Sandri-Goldin RM, Silverstein SJ. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J Virol 1997; 71: 9188-9197.
29. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
30. Xu R et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Therapy 2001; 8: 1323-1332.
31. Zolotukhin S et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2002; 28: 158-167.